Literature DB >> 30390000

Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing.

Taha Mohseni Ahooyi1, Masoud Shekarabi1, Bahareh Torkzaban1, T Dianne Langford1, Tricia H Burdo1, Jennifer Gordon1, Prasun K Datta1, Shohreh Amini1, Kamel Khalili2.   

Abstract

HIV-1 Tat protein is released from HIV-1-infected cells and can enter non-permissive cells including neurons. Tat disrupts neuronal homeostasis and may contribute to the neuropathogenesis in people living with HIV (PLWH). The use of cocaine by PLWH exacerbates neuronal dysfunction. Here, we examined the mechanisms by which Tat and cocaine facilitate alterations in neuronal homeostatic processes. Bioinformatic interrogation of the results from RNA deep sequencing of rat hippocampal neurons exposed to Tat alone indicated the dysregulation of several genes involved in lipid and cholesterol metabolism. Following exposure to Tat and cocaine, the activation of cholesterol biosynthesis genes led to increased levels of free cholesterol and cholesteryl esters in rat neurons. Results from lipid metabolism arrays validated upregulation of several processes implicated in the biogenesis of β-amyloid and Alzheimer's disease (AD), including sterol o-acyltransferase 1/acetyl-coenzyme A acyltransferase 1 (SOAT1/ACAT1), sortilin-related receptor L1 (SORL1) and low-density lipoprotein receptor-related protein 12 (LRP12). Further studies in Tat-treated primary neuronal cultures and brain tissues from HIV-1 transgenic mice as well as SIV-infected macaques confirmed elevated levels of SOAT1/ACAT 1 proteins. Our results offer novel insights into the molecular events involved in HIV and cocaine-mediated neuronal dysfunction that may also contribute to neuropathogenic events associated with the development of AD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30390000      PMCID: PMC6215004          DOI: 10.1038/s41598-018-34539-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  74 in total

1.  HIV associated dementia: role for neurosteroids.

Authors:  Madhusoothanan Bhagavathi Perumal; Saranya Dhanasekaran
Journal:  Med Hypotheses       Date:  2012-03-03       Impact factor: 1.538

Review 2.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

3.  Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse.

Authors:  Amanda N Carey; Elizabeth I Sypek; Harminder D Singh; Marc J Kaufman; Jay P McLaughlin
Journal:  Behav Brain Res       Date:  2011-12-20       Impact factor: 3.332

Review 4.  Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.

Authors:  Qing Wang; Junqiang Yan; Xiaohong Chen; Jin Li; Yu Yang; Jianping Weng; Chao Deng; Midori A Yenari
Journal:  Exp Neurol       Date:  2010-04-18       Impact factor: 5.330

5.  Enrichment map: a network-based method for gene-set enrichment visualization and interpretation.

Authors:  Daniele Merico; Ruth Isserlin; Oliver Stueker; Andrew Emili; Gary D Bader
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

6.  The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation.

Authors:  Eoin R Feeney; Nuala McAuley; Jane A O'Halloran; Clare Rock; Justin Low; Claudette S Satchell; John S Lambert; Gerald J Sheehan; Patrick W G Mallon
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

7.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

8.  Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.

Authors:  Kristen A McLaurin; Hailong Li; Rosemarie M Booze; Amanda J Fairchild; Charles F Mactutus
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

9.  Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.

Authors:  Ming D Li; Junran Cao; Shaolin Wang; Ju Wang; Sraboni Sarkar; Michael Vigorito; Jennie Z Ma; Sulie L Chang
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

10.  HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?

Authors:  Deanna A Kulpa; Nicolas Chomont
Journal:  J Virus Erad       Date:  2015-04
View more
  11 in total

1.  Region-specific effects of HIV-1 Tat on intrinsic electrophysiological properties of pyramidal neurons in mouse prefrontal cortex and hippocampus.

Authors:  Thomas J Cirino; Scott W Harden; Jay P McLaughlin; Charles J Frazier
Journal:  J Neurophysiol       Date:  2020-02-26       Impact factor: 2.714

Review 2.  Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis.

Authors:  Harini Hariharan; Yasodha Kesavan; Natesan Sella Raja
Journal:  Mol Biol Rep       Date:  2021-10-09       Impact factor: 2.316

3.  Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation.

Authors:  Marina Aksenova; Justin Sybrandt; Biyun Cui; Vitali Sikirzhytski; Hao Ji; Diana Odhiambo; Matthew D Lucius; Jill R Turner; Eugenia Broude; Edsel Peña; Sofia Lizarraga; Jun Zhu; Ilya Safro; Michael D Wyatt; Michael Shtutman
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-04       Impact factor: 4.147

4.  HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status.

Authors:  Alaa N Qrareya; Fakhri Mahdi; Marc J Kaufman; Nicole M Ashpole; Jason J Paris
Journal:  Geroscience       Date:  2020-09-17       Impact factor: 7.713

Review 5.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

6.  Perturbation of synapsins homeostasis through HIV-1 Tat-mediated suppression of BAG3 in primary neuronal cells.

Authors:  Taha Mohseni Ahooyi; Bahareh Torkzaban; Masoud Shekarabi; Farzaneh G Tahrir; Emilie A Decoppet; Bianca Cotto; Dianne Langford; Shohreh Amini; Kamel Khalili
Journal:  Cell Death Dis       Date:  2019-06-17       Impact factor: 8.469

Review 7.  Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir.

Authors:  Shilpa Sonti; Kratika Tyagi; Amit Pande; Rene Daniel; Adhikarimayum Lakhikumar Sharma; Mudit Tyagi
Journal:  Vaccines (Basel)       Date:  2022-01-27

Review 8.  Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Emaya Moss; Nicholas S Akins; Jing Li; Hoang V Le; Jason J Paris
Journal:  J Neuroendocrinol       Date:  2021-10-14       Impact factor: 3.870

Review 9.  Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.

Authors:  Dmitri Sviridov; Nigora Mukhamedova; Alexander A Makarov; Alexei Adzhubei; Michael Bukrinsky
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

10.  HIV-1 Tat Dysregulates the Hypothalamic-Pituitary-Adrenal Stress Axis and Potentiates Oxycodone-Mediated Psychomotor and Anxiety-Like Behavior of Male Mice.

Authors:  Mohammed F Salahuddin; Fakhri Mahdi; Jason J Paris
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.